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ABSTRACT: Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotland
in 1958 and further reports of resistance, both in this species and in others, soon followed from other parts of Europe
and the United States. Researchers quickly defined the practical impact of these resistance phenomena and developed
robust methods by which to monitor their spread. These tasks were relatively simple because of the high degree of
immunity to warfarin conferred by the resistance genes. Later, the second generation anticoagulants were introduced
to control rodents resistant to the warfarin-like compounds, but resistance to difenacoum, bromadiolone and brodifacoum
is now reported in certain localities in Europe and elsewhere. However, the adoption of test methods designed initially
for use with the first generation compounds to identify resistance to compounds of the second generation has led to some
practical difficulties in conducting tests and in establishing meaningful resistance baselines. In particular, the results
of certain test methodologies are difficult to interpret in terms of the likely impact on practical control treatments of the
resistance phenomena they seek to identify. This paper defines rodenticide resistance in the context of both first and
second generation anticoagulants. It examines the advantages and disadvantages of existing laboratory and field methods
used in the detection of rodent populations resistant to anticoagulants and proposes some improvements in the application
of these techniques and in the interpretation of their results.
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anticoagulants, such as brodifacoum, bromadiolone and
difenacoum, has never become as widespread as that to
the first generation compounds and nowhere is it
impossible to control rodents with at least one of these
materials (Buckle 1994). Nevertheless, great interest
remains both among researchers and pest control
practitioners in the resistance phenomenon; the former in
their attempts to measure and record the development and
spread of resistance in different rodent species and the
latter in their desire to conduct effective rodent control
programs.

INTRODUCTION
The development of resistance in rodents to the
anticoagulant rodenticides threatened the great strides
towards improved efficacy and safety that the introduction
of these compounds had made possible. This
phenomenon was first discovered among Norway rats
(Rattus norvegicus) in Scotland in 1958 (Boyle 1960) but
the initial outbreak was quickly followed by others
occurring in the United Kingdom (UK) (Drummond
1966a), Denmark (Lund 1988), the United States (USA)
(Jackson and Kaukeinen 1972) and elsewhere. Some of
these resistance foci spread rapidly in spite of rigorouslyapplied and varied attempts to overcome them. Others
were successfully managed, either so that they
disappeared completely or their spread was substantially
curtailed. Still other foci seemed to disappear without
human intervention (see Smith and Greaves 1987 for a
review). Meanwhile, the other important commensal
rodent pest species, the House mouse (Mus musculus/
domesticus), never very susceptible to the early
anticoagulant compounds such as warfarin, diphacinone
and coumatetralyl, also developed resistant populations in
several countries (Wallace and MacSwinney 1976, Ash ton
and Jackson 1984).
The discovery of the second generation compounds
(Hadler and Shadbolt 1972) redressed the balance for
several years but, in a few localities, resistance to the first
generation anticoagulants brought with it a measure of
cross resistance to the second generation compounds and
soon populations of rats and mice began to appear with
reduced susceptibility to these more potent compounds
(Greaves et al. 1982). However, resistance to the modern

DEFINITIONS OF RESISTANCE
The term resistance means different things to
different people. Researchers commonly define it as "the
development of an ability in a strain of a pest to survive
doses of a toxicant which would prove lethal to the
majority of individuals of a normal population of the same
species." In other words, if a technique can be applied
which distinguishes between the susceptibility of
individuals belonging to two strains of a pest species, the
less susceptible strain may be considered "resistant."
Such a definition is important to those wishing to detect
the early onset of resistance, perhaps to allow the
implementation of measures to interrupt its spread.
However, it gives no indication of the likely practical
significance of the resistance phenomenon described. To
the pest control practitioner, a statement that defines a
species as resistant to an anticoagulant rodenticide implies
that the compound will be ineffective when used against
it. But it is evident from the foregoing that this is not
necessarily the case.
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Greaves (1994) recently conceived the following
definition:
Anticoagulant resistance is a major loss of
efficacy in practical conditions where the
anticoagulant has been applied correctly, the
loss of efficacy being due to the presence of a
strain of rodent with a heritable and
commensurately reduced sensitivity to the
anticoagulant.
This definition encompasses three important elements.
Firstly, that the phenomenon described as resistance
should involve a significant change in susceptibility that
brings about a practical effect. Thus, where the term
resistance is applied to a compound and pest species,
practitioners should anticipate a real loss of efficacy at the
resistance focus. Secondly, that the compound should
have been applied correctly and, incidentally, be normally
effective for the species involved. Often, when an
anticoagulant treatment fails, the cause is attributed to
resistance when the real reason is faulty application.
Thirdly, that the resistance should have a genetic basis
that makes it transmissible between rodent generations.
If the term resistance is to be reserved for cases
satisfying these criteria, what term should be used when
a heritable change of susceptibility is observed that falls
short of this definition in terms of its practical effect?
Gill et al. (1992) introduced the phrase "low grade
resistance" to describe a situation of this type. However,
unless genetical experiments are done, it is very difficult
to distinguish between this phenomenon and differences in
the response of rodent populations to anticoagulants that
would be predicted on the basis of natural variability.
Rodenticide resistance in the sense defined by
Greaves (1994) has been found only to the anticoagulant
compounds. Therefore, in this paper we will restrict
ourselves to dealing with these compounds, which are the
basis of the majority of rodent control program
worldwide. The main purpose of the paper is to present
a critical review of the methods currently used in the
detection of resistance to anticoagulants. Later we will
look at some anticoagulant resistance phenomena detected
in the UK and judge them against the definition of
Greaves (1994).
RESISTANCE DETECTION METHODS
It quickly became apparent to those investigating
early outbreaks of resistance to warfarin in Norway rats
in the UK that methods were required by which to
distinguish resistant rat infestations from normally
susceptible ones. The two lines of research initially
followed were described by Drummond (1966b). The
first involved a method in which the effectiveness of field
applications of warfarin against suspected warfarinresistant Norway rats were compared with the results of
treatments against anticoagulant-naive populations. This
technique became known as the resistance "monitoring
graph" method and was fully described by Drummond and
Rennison (1973). A second method was developed
following the same principle but based on laboratory
testing techniques. This became known as the World
Health Organization (WHO) "lethal feeding period" test
because its result was a discriminating dose of the

anticoagulant under investigation, expressed in terms of
the number of days of consecutive feeding (the lethal
feeding period or LFP), that would kill a defined
percentile of normally susceptible animals (WHO 1982).
A third line of research resulted in the development of
another laboratory resistance detection technique base
upon differences observed in the contrasting abilities of
the blood of warfarin-susceptible and warfarin-resistant
rats to clot after the administration of warfarin (Martin et
al. 1979).
Resistance Monitoring Graph
As a susceptible rodent population feeds on poisoned
bait in a practical rodent control treatment, the numbers
of takes of bait from bait points and the quantity of bait
eaten increases at first and then quickly decreases as the
poison takes effect. Drummond and Rennison (1973)
recorded this process in relation to three populations of
warfarin-susceptible Norway rats exposed to either 0.005
or 0.025% warfarin. The data were pooled for the three
treatments and plotted, as a regression equation, on a
graph in which the abscissa was the day of the recording
visit, expressed as a common logarithm, and the ordinate
was the number of bait points with takes, expressed as a
proportion of the number of takes recorded on the second
day of the treatment. The 95 % confidence limits for the
expected bait take at any given time were calculated and
also plotted. The derived graph therefore illustrates the
expected effect of the application of warfarin against
susceptible Norway rats infesting UK farmsteads.
The results of treatments, in which the susceptibility
status of the infestation is unknown, may be plotted on
the derived graph as a test for the presence of resistance.
If the decline in bait takes with time follows the normal
course, and the plotted line remains within the 95%
confidence limits, the treated population is determined to
be warfarin-susceptible. If the plotted line moves outside
the upper 95% confidence limit for two successive baiting
visits, the infestation is considered warfarin-resistant.
However, the confidence limits chosen will give this
result by chance alone on one occasion in forty and for
this reason, and others, the authors recommended
confirmatory laboratory test to be carried out on captured
survivors of unsuccessful treatments. This method was
widely used in the UK, not only for establishing the
susceptibility status of suspected resistant populations but
also as a method of determining the effectiveness of
novel, resistance-breaking rodenticides against warfarinresistant rat populations (e.g., Rennison and Dubock
1978).
The method has a number of flaws, both practical
and statistical in nature. Rennison (1977) pointed out that
complete cessation of feeding did not necessarily indicate
that the rat infestation had been extinguished unless a
careful examination of the site confirmed no other signs
of continuing rat activity. The studies of Quy et al.
(1992) have further emphasized the need for care in the
interpretation of results when the effectiveness of
treatments is assessed only by bait take data.
While experience has proven the original monitoring
graph to have been robust for its purpose, there is
considerable potential for improving its statistical basis.
When data are pooled from several sites to obtain a single
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mortality and absolute time rather than log time are
arguably equally appropriate. The effect of the model
used is apparent when the data of Buckle et al. (1980) are
examined using each of the four possible models (Table

regression line there must be confidence that the data
employed are homogeneous. In this case, the three farm
sites and the results Drummond and Rennison obtained
from them show clear signs of heterogeneity
(notwithstanding the obvious fact that, at one site, the
concentration of warfarin in the bait differed from that
used at the other two). This implies that the expected
relationship between the decline in the number of bait
takes and time is not fixed but may vary from one site to
another. The authors also neglected the fact that the
width of the 95% confidence limits would be expected to
differ depending on the number of bait points monitored
on the farms (i.e., sample size); the limits being wider for
farms with smaller numbers of points. Furthermore, the
regression equation applied assumed a linear relationship
between log time and the numbers of bait takes. There is
evidence that the relationship observed better fits a curve
and, therefore, a suitable transformation should have been
applied or a non-linear model fitted to the data.
In spite of these drawbacks, the monitoring graph
offers the most easily interpreted positive indication of the
existence of a resistant rat infestation. That is, when the
rodenticide in question is used, as directed, against a
natural pest infestation, it demonstrably fails to provide an
acceptable level of control in comparison to its
performance against a fully susceptible rat population. Of
course, further laboratory work on the inheritance of the
resistance trait is required before the definition of Greaves
(1994) is fully satisfied.

There is no obvious biological reason why any one
of the models used in Table 1 is more correct than any
other. Nor does any of the four calculated dose-response
relationships fit the observed data better than any other.
Thus, at the LFP,, percentile recommended by the WHO,
discriminating doses ranging from 11 days to 20 days are
equally valid. In this unsatisfactory situation it is
prudent, therefore, to adopt a less extreme LFP percentile
at which the effect of the model used is unimportant. For
example, Table 1 shows the discriminating dose to be
eight days for all four models at the LFP^. The use of
this percentile has the additional benefits that the feeding
tests are of shorter duration and that the discriminating
dose is derived by interpolation rather than by the less
reliable method of extrapolation.
The WHO lethal feeding period test has been widely
applied to first generation anticoagulants and to one of the
second generation compounds (i.e., difenacoum, Redfern
and Gill 1978). However, difficulties are encountered
when using the technique to derive discriminating doses
to detect resistance to the more potent compounds. This
is because the steep slope of the dose-response curve does
not allow sufficient data points for proper statistical
analysis (Gill and MacNicoll 1991). For example, all
susceptible Norway rats succumb to a single day of
feeding on 0.005% brodifacoum and flocoumafen baits
(Buckle 1994). In this case, the WHO guidelines
recommend that the concentration of the anticoagulant in
the bait should be reduced to produce survivors at a
sufficient number of dosage (days) intervals. Gill and
MacNicoll (1991) used 0.0005% brodifacoum bait (10%
of the concentration of active ingredient normally used in
rodenticide treatments) to establish a discriminating dose
of brodifacoum and pointed out the difficulty of this
approach. However, the result was the anomalous
situation of rats being declared "resistant" to the
compound in spite of the fact that they succumb to baits
containing it at full field strength (i.e., 0.005%). The
difficulty of determining the impact of this so-called
resistance on the outcome of practical control treatments
is readily apparent and certainly, in this case, the criteria
for true resistance proposed by Greaves (1994) are not
met.

World Health Organization (WHO) Lethal Feeding Period
Test
This second methodology employs the same basic
principles as the previous technique but the
experimentation is laboratory-based. A susceptibility
base-line is established using wild-captured animals from,
preferably, anticoagulant-naive populations. Groups of
these animals are fed, for differing numbers of days, a nochoice diet comprising a bait containing the poison under
study at the strength normally used in control
programmes. A dose-response curve is constructed in a
similar way to that employed in tests to determine the
acute oral LD^ of a compound but, in this case, feeding
periods in days are used as the dose variable instead of
differing quantities of active ingredient. Thus, lethal
feeding period (LFP) percentiles are calculated rather than
lethal dose (LD) percentiles.
This process is typified by the work of Buckle et al.
(1980) to establish the susceptibility of the South-east
Asian rice rat (Rattus argentiventer) to baits containing
0.025% warfarin. No-choice feeding periods of 2, 4, 6,
8, 10 and 12 days gave mortalities of 27.5, 57.5, 82.5,
87.5, 97.5 and 100% respectively. These data were used
to construct a dose-response curve and, following WHO
Guidelines (WHO 1982), the LFP,, was calculated to be
15.1 days, giving a 16-day no-choice feeding period on
0.025 % warfarin bait as the checking test for resistance
in this species (Buckle 1983).
The recommended statistical method for the analysis
of these data (WHO 1982) is that of Finney (1971), in
which the dose variable (days) is expressed as a logarithm
and the response variable (percent mortality) as a probit.
However, other models for instance involving logit

Resistance Ratios
If the LFP test is inappropriate for use with the
potent second generation anticoagulants, how then should
resistance to them be monitored? The concept of the
lethal feeding period was introduced in rodenticide
resistance testing to overcome difficulties presented by the
chronic nature of the first generation anticoagulants, such
as warfarin, and the consequent requirement to administer
them over several days for full effect. However,
resistance to other pesticides (e.g., insecticides) is more
normally established by the comparison of dose-response
data from susceptible and resistant strains in which the
dose variable is an administered quantity of the compound
in question, rather than a period of time. It seems
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Table 1. The data on the susceptibility of R. argentiventer to 0.25% warfarin (Buckle et al. 1980) are
here used to demonstrate the effect of the model used to derive discriminating doses for use in checking
tests for anticoagulant resistance using the WHO lethal feeding period method.

As in the previous tests, base-line observations were
first required. In BCR tests the response variable is the
reduction in blood clotting activity. This is measured as
a clotting time and expressed as a percentage (of normal)
coagulation activity (PCA). Coagulation times are
determined using commercially available test methods
(e.g., "Thrombotest") and converted to PCAs by
reference to calibration curves. These curves are
generated by determining coagulation times for a blood
(or plasma) dilution series prepared form pooled blood
samples from specific numbers of male and female
animals. Thus, a blood sample with a PCA of 50% has
a coagulation time equivalent to that of a 50% dilution of
the pooled normal blood sample.
The next step in the development of the warfarin
BCR test was to derive a discriminating dose of warfarin
required to produce a specific effect on the blood
coagulation of susceptible rats. (The effect chosen by
Martin et al. (1979) was a reduction of blood clotting
activity to less than 17% of that seen in normal animals.)
This was done by administering graduated doses of
warfarin to groups of animals and observing, 24 hours
later, their effect in preventing blood coagulation in
different proportions of the animals tested. Vitamin K,
epoxide was co-administered with the anticoagulant to
reduce the tendency of resistant animals to become
Vitamin K deficient.
Martin et al. (1979) proposed a discriminating dose
of 0.5 mg of warfarin per 100 g of animal body weight.
This was administered in saline solution with 0.1 mg per
100 g of Vitamin K, epoxide. When this dosage was
given to 212 Norway rats, all warfarin resistant animals
had PCAs that were greater than 17% and all warfarin
susceptible animals had a PCAs less than 17 %. Thus, the
chosen dose was effective in discriminating resistant and
susceptible Norway rats. The same authors went on to
develop the test method further so that homozygous and
heterozygous resistant animals could be distinguished.
MacNicoll and Gill (1993a) revised this method,
replacing Vitamin K, epoxide with a water-soluble form
of Vitamin K3 (menadione sodium bisulphite or MSB) and
also using a water-soluble form of the anticoagulant,
sodium warfarin. In the new test, both anticoagulant and
vitamin are administered by oral intubation rather than by

sensible then to revert to this methodology with the
second-generation anticoagulants which are active after
single doses.
Lethal dose (LD) percentiles can be determined in
base-line experiments in which graded doses of the
anticoagulant are given to groups of susceptible animals.
To assess the resistance status of rodent populations,
equivalent tests can be conducted with groups of suspected
resistant animals and the relationship, at a certain LD
percentile, between the potency of the active ingredient in
susceptible and resistant animals expressed as a
conventional "resistance ratio." Reference to established
Norway rat resistance ratios for the second generation
anticoagulants in existing resistance foci (Greaves 1994)
would assist in determining the likely practical impact of
any resistance detected. For tests on individual rodents,
a certain LD percentile dose, say the LD99 or a multiple
of it, can be used in checking tests. Further work is
required, however, to establish the potential of these
proposals to provide effective and practicable resistance
tests. Particularly, it is important to recognize that this
technique would be expected to reflect accurately the
resistance status of populations only when the frequency
of the resistant phenotype is high. If the frequency is
low, even a very high level of resistance in resistant
individuals would not result in a significantly increased
resistance ratio (Ward, personal observations).
Blood Clotting Response (BCR) Tests
As warfarin resistance (and cross-resistance to many
of the other first generation anticoagulants) took hold in
Norway rat populations in the UK, work began towards
the development of more cost-effective tests to determine
the resistance status of these rodents. This was because
the tests described in the preceding paragraphs required
either extensive field investigations or laboratory
experiments of many weeks duration. Work on the
biochemistry of resistance (Bell and Caldwell 1973) led to
the observation that, in the Vitamin K cycle, the reduction
of Vitamin K, epoxide to the quinone was less liable to
inhibition by warfarin in resistant than in susceptible rats.
Martin et al. (1979) used this effect in the development of
a blood clotting response (BCR) test to distinguish
warfarin resistant from warfarin susceptible Norway rats.
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intraperitoneal injection. Subsequently, Gill et al. (1993)
proposed a BCR test for difenacoum resistance and a test
for resistance to bromadiolone is also available (Gill et al.
1994).
The doses of active ingredient and Vitamin K
administered, the time from the administration of
anticoagulant to measurement of PCA and the threshold
PCA selected for each of these tests are summarized in
Table 2.
Blood clotting response tests have a number of
significant advantages. The tests are conducted in the
laboratory and provide rapid assessments of the resistance
status of individual rodents. They are not necessarily
lethal to the animals tested because an effective dose of
antidote can be administered after PCA assessment. This
has benefits in the welfare of the animals used and
permits the resistance status of individuals to be
determined sequentially to a number of different
compounds. It also allows animals to be used in later
breeding studies in which the genetical basis of any
resistance observed can be studied. The tests are very
sensitive and can be used to detect small differences in the
susceptibility of individual rodents to anticoagulants.
However, some difficulties are associated with the
use of the method. It relies on comparative measurements
of the physiological effects of anticoagulants in susceptible
and resistant rodents. Such observations provide no direct
indication of the practical impact of the resistance
observed and further work is required for this to be to
determined. Because of the sensitivity of the tests,
relatively small differences in the susceptibility of rodent
populations to anticoagulants can be demonstrated and
there is a risk that naturally-occurring intraspecific
variation can be classified as "resistance." There is
evidence that Vitamin K3 is antidotal to the effects of
anticoagulants in resistant, but not in susceptible, rodents
(MacNicoll and Gill 1993b). Therefore, care is required
when using MSB to prevent resistant animals from
becoming vitamin K deficient during BCR tests to avoid
producing a confounding antidote effect.

PRACTICAL USE OF RESISTANCE TESTS
The most thoroughly researched anticoagulant
resistance focus in the UK is the area in which warfarinresistant Norway rats infest farmsteads on the AngloWelsh border. In this locality, the resistance monitoring
graph has been used successfully in the assessment of
novel, resistance-breaking anticoagulants (e.g., Rennison
and Dubock 1978) and both LFP and BCR tests have
been developed for resistance detection (Drummond and
Wilson 1968, Martin et al. 1979). These tests accurately
reflect a resistance situation in which warfarin is almost
useless for the control of Norway rat populations
containing a high percentage of resistant animals.
Resistance in R. norvegicus to the second-generation
compound, difenacoum, was reported on farms in central
southern England soon after the introduction of the
compound (Greaves et al. 1982). A WHO lethal feeding
period test was established for the detection of
difenacoum resistance (Redfern and Gill 1978) and,
subsequently, a BCR test was also developed (Gill et al.
1993). Rats were trapped from farms in the resistance
area and found to be resistant to difenacoum using both
detection methods. However, Greaves and Cullen-Ayres
(1988) speculated that the level of resistance to
difenacoum observed at the focus (the resistance ratio is
four-fold) was insufficient to account for the severity of
the practical problem. Later, extensive field studies
revealed that control difficulties were primarily due to
behavioral factors, principally the constant availability of
alternative food sources that made the rat infestations very
difficult to bait (Quy et al. 1992, Quy et al. these
proceedings).
A further focus of resistance to the second-generation
anticoagulants was found to occur in Berkshire. At this
site, rats are fully resistant, in practical terms, to
bromadiolone (Prescott, personal observations) and work
is in progress to determine a resistance ratio for this
compound by the method proposed above. These
infestations also contain individuals that survive the
brodifacoum LFP test of Gill and MacNicoll (1991),

Table 2. Some parameters used in blood clotting response tests for detecting resistance to anticoagulants in
Norway rats.
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which involves feeding for seven days on 0.0005%
brodifacoum. However, none would be expected to
survive feeding on full strength (i.e., 0.005%)
brodifacoum baits and the efficacy of brodifacoum for the
control of these infestations remains to be determined.
These observations serve to illustrate the difficulties
facing those who try to interpret, in terms of likely
practical effect on rodent control, the results of laboratory
experiments conducted to determine the resistance status
of rodent populations. The foregoing also suggests that
more research is required before statistically valid and
fully reliable resistance detection methods are available.
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